Neovasc (NVCN) Reports Q4 Loss of $0.14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Neovasc Announces Results for the Fourth Quarter and Full Year Ended 2014
March 30, 2015 7:00 AM EDTNASDAQ: NVCNTSX: NVC
VANCOUVER, March 30, 2015 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced financial results for the fourth quarter and full year ended December 31, 2014. All results are reported in Canadian dollars unless otherwise stated.
2014 Highlights
First-in-human implantation of Tiara transcatheter mitral valve was successfully performed at St. Paul's Hospital in Vancouver, BC. Initiated TIARA-I, the FDA approved Early Feasibility trial that will enrol approximately 30 patients at participating... More